Open Access
| Issue |
BIO Web Conf.
Volume 237, 2026
2026 8th International Conference on Biotechnology and Biomedicine (ICBB 2026)
|
|
|---|---|---|
| Article Number | 01027 | |
| Number of page(s) | 7 | |
| Section | Molecular and Cellular Pathophysiology | |
| DOI | https://doi.org/10.1051/bioconf/202623701027 | |
| Published online | 10 June 2026 | |
- Smolarz B, Nowak AZ, Romanowicz H. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers (Basel). 2022;14(10):2569. Published 2022 May 23. doi:10.3390/cancers14102569 [Google Scholar]
- Ma L, Song G, Li M, et al. Construction and Comprehensive Analysis of a ceRNA Network to Reveal Potential Novel Biomarkers for Triple-Negative Breast Cancer. Cancer Manag Res. 2020;12:7061–7075. Published 2020 Aug 7. doi:10.2147/CMAR.S260150 [Google Scholar]
- Tiwari H, Singh S, Sharma S, et al. Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities. Med Res Rev. 2025;45(3):817–841. doi:10.1002/med.22090 [Google Scholar]
- Gari M, Baothman BK, Gari K, et al. A combined transcriptomic, epigenetic, and functional analysis identifies novel biomarkers in breast cancer. Hereditas. 2025;163(1):16. Published 2025 Dec 27. doi:10.1186/s41065-025-00630-1 [Google Scholar]
- Iqbal A, Ali F, Ali Alharbi S, et al. Integrated analysis of hub genes and intrinsically disordered regions in triple-negative breast cancer. J Genet Eng Biotechnol. 2024;22(4):100408. doi:10.1016/j.jgeb.2024.100408 [Google Scholar]
- Krishnamoorthy HR, Karuppasamy R. Deciphering the prognostic landscape of triple-negative breast cancer: A focus on immune-related hub genes and therapeutic implications. Biotechnol Appl Biochem. 2025;72(3):825–845. doi:10.1002/bab.2700 [Google Scholar]
- Walker C, Kollarovic G, Weekes D, et al. Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors. Nat Commun. 2026;17(1):2157. Published 2026 Mar 11. doi:10.1038/s41467-026-69561-3 [Google Scholar]
- Lu Y, Yang G, Xiao Y, et al. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis. Breast Cancer. 2020;27(5):903–911. doi:10.1007/s12282-020-01086-z [Google Scholar]
- Lundberg A, Lindström LS, Li J, et al. The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours. Breast Cancer Res. 2019;21(1):34. Published 2019 Feb 28. doi:10.1186/s13058-019-1121-4 [Google Scholar]
- Walker C, Kollarovic G, Weekes D, et al. Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors. Nat Commun. 2026;17(1):2157. Published 2026 Mar 11. doi:10.1038/s41467-026-69561-3 [Google Scholar]
- Berke TP, Slight SH, Hyder SM. Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer. Onco Targets Ther. 2022;15:23–30. Published 2022 Jan 8. doi:10.2147/OTT.S342292 [Google Scholar]
- Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2(3):161–174. doi:10.1038/nrc745 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.